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HIGHLIGHTS
• Glucose transporter Glut2 defines a subpopulation of glucose-sensing neurons in NTS
• NTS Glut2 neurons are excited when glucose levels drop
• Glucose sensing involves leak K + channels, cellular glucose metabolism and AMPK
• Glut2 neurons are GABAergic cells controlling vagal output and glucagon secretion INTRODUCTION Feeding, energy expenditure, and glucose homeostasis are processes that are regulated by many signals reflecting the metabolic status of the organism. Nutrients, including glucose, lipids and amino acids, play a particularly important role in orchestrating these responses by directly controlling the secretion of hormones such as insulin and glucagon, and by modulating the activity of the autonomic nervous system to coordinate the adaptation of peripheral organs to changes in energy metabolism (Schwartz et al., 2000; Thorens, 2012) .
Glucose-sensing neurons have been identified and classified in two major categories, glucose excited (GE) and glucose inhibited (GI), depending on the effect of extracellular glucose on their firing activity (Routh, 2002) . There is evidence for a large diversity in the mechanisms of neuronal glucose-sensing and for their wide topographical distribution (Thorens, 2012) . It is established that the hypothalamus and brainstem are important centers that integrate nutrient, hormonal and nervous signals controlling energy metabolism. Evidence has been provided that NPY and POMC neurons in arcuate nucleus (AN), MCH and orexin neurons of the lateral hypothalamus (LH), as well as a large number of neurons from the ventromedial hypothalamus (VMH) are glucose-responsive and may control adaptive responses to hypo-or hyperglycemia (Gonzalez et al., 2009; Kang et al., 2004; Parton et al., 2007) . In the brainstem, the dorsal vagal complex (DVC), which consists in the area postrema (AP), the nucleus of the tractus solitarius (NTS), and the dorsal motor nucleus of the vagus (DMNX), also contains GE and GI neurons (Balfour et al., 2006; Balfour and Trapp, 2007) . These neurons are involved in various glucoregulatory functions, including the stimulation of feeding and glucagon secretion in response to hypoglycemia and the increase of insulin secretion in response to hyperglycemia (Marty et al., 2005; Marty et al., 2007; Ritter et al., 2000) . They also control gastric motility (Ferreira et al., 2001; Grill and Hayes, 2012) . Although there is abundant evidence for the presence of glucose-sensing neurons in brainstem, the lack of specific markers hampers a clear identification of these cells and any further characterization of their molecular mechanisms of glucose detection, and of the neuronal circuits in which they are integrated.
In previous studies we reported that expression of the glucose transporter Glut2 in the brain is required for several glucoregulatory responses, including glucagon secretion (Marty et al., 2005) , feeding (Bady et al., 2006) , and thermoregulation (Mounien et al., 2010) . Using a genetic reporter system we showed that Glut2-expressing neurons were scattered in different hypothalamic nuclei, including the LH, VMH, paraventricular hypothalamus and the zona incerta (Mounien et al., 2010) . In the AN, Glut2-expressing nerve terminals were found in contact with NPY and POMC neurons, which did not express themselves this gene. Glut2 neurons were also found in brainstem, in particular in the DVC. In this structure, neuroglucopenia activated c-fos expression in Glut2 cells, suggesting that they are GI neurons (Mounien et al., 2010) . More recently, we showed that Glut2 inactivation in the nervous system (NG2KO mice) led to suppressed regulation by glucose of the parasympathetic and sympathetic nerve activity. This caused impaired proliferation of beta-cells during the weaning period, reduced adult beta-cell mass, suppression of first phase insulin secretion, and progressive development of glucose intolerance. When NG2KO mice were fed a high fat diet, glucose intolerance developed faster and glucagon secretion became deregulated (Tarussio et al., 2014) . Thus, Glut2-expressing cells in the nervous system are involved in the control by glucose of the autonomic nervous activity, which controls endocrine pancreas development and function. However, the specific role of Glut2-neuron subpopulations present in different hypothalamic and brainstem nuclei is not yet defined.
Here, we report the electrophysiological properties of Glut2-neurons of the NTS, which form a homogeneous population of GI neurons mechanistically dependent on intracellular glucose metabolism, AMP-Kinase and activation of a leak K + current. Furthermore, we find that these neurons are GABAergic interneurons sending projections to the DMNX. We show that when activated by optogenetic tools, they increase parasympathetic activity and stimulate glucagon secretion, thus defining a neuronal circuit linking hypoglycemia detection to counterregulatory response.
RESULTS

Glut2 Cells Are Glucose-Sensing Neurons Excited by Low Glucose Levels
To identify Glut2-expressing cells in brainstem, we crossed Glut2-Cre mice (Mounien et al., 2010 ) with a Rosa26tdTomato reporter line (Madisen et al., 2010) . We observed clusters of tdTomato-positive (tdT+) cells in the NTS of resulting animals ( Figure 1A ). These cells were more frequently found in the caudal and dorsal aspects of the NTS, in agreement with existing reports on the anatomical localization of Glut2 cells in the brainstem (Arluison et al., 2004) .
They appeared as multipolar neurons with extensive projections in and outside from NTS ( Figure 1A) . We performed whole-cell patch-clamp recordings in acute brainstem slices to analyze their electrophysiological properties ( Figure 1A and Table S1 ). TdT+ cells were not spontaneously active, however, they fired accommodating spike trains when stimulated by depolarizing current injection ( Figure 1B ). Single-cell RT-PCR (scRT-PCR) amplification performed on cytosols collected at the end of electrophysiological recordings detected expression of Glut2 in 67% of tdT+ cells ( Figure 1C) . The failure to detect Glut2 in every cell we attribute to the low levels of expression of this gene (Arluison et al., 2004) and the low sensitivity of scRT-PCR. Because of this and the absence of Glut2 detection in all tested tdT-cells (not shown),
we concluded that the tdTomato reporter system selectively labeled Glut2-expressing cells.
We assessed whether Glut2 neurons sensed extracellular glucose level by recording their electrical properties while changing glucose concentration in the superfusion buffer. Switching from 5 to 0.5mM glucose produced a reversible increase in resting membrane potential (Vm) of 6.7±1.0mV (p<2 x 10 -5 , n=13) and in input resistance (Rinput) of 451±75MΩ (p<6 x 10 -5 , n=13) ( Figure 1D-E) . This glucose response pattern was observed consistently in all the tdT+ cells we recorded (n=25). By contrast, neighboring tdT-neurons were unresponsive to a similar change in glucose concentration (ΔVm=-0.2±0.4mV, p>0.53, n=5; ΔRinput=-129±133MΩ, p>0.38; n=5), indicating that this effect is specific to Glut2 cells ( Figure S1A-B) . The response of tdT+ neurons to glucose was not altered when experiments where repeated in the presence of inhibitors of synaptic transmission (ΔVm=5.5±1.0mV, p<0.0002, n=12; ΔRinput=395±79MΩ, p<0.0004, n=12), demonstrating a cell-autonomous effect ( Figure 1D-E) .
To test the impact of glucose-dependent variations in resting membrane properties on cell excitability, we injected depolarizing current steps and plotted the observed firing rates as a function of injected current intensity (FI curve). Switching from 5mM to 0.5mM glucose increased the firing frequency for the same amount of current injected (Figure 1F ), leading to an increase in the slope of the FI curve (FI gain) of 0.082±0.020 Hz/pA (p<0.0025, n=10; Figure   1F -G). This increase in excitability was confirmed by a decrease in the minimal amount of current required to trigger action potentials (Rheobase) of 30.8±9.4pA (p<0.0073, n=12; Figure   1G ). The absence of any glucose effect on single action potential and spike train properties ( Figure 1G ), confirming that lowering glucose increased cell excitability independently from neuronal network activity.
We further determined that passive membrane properties and indices of cell excitability (FI gain and rheobase) changed monotonically with intermediate glucose concentrations ( Figure   1H ). Thus, Glut2 neurons reliably detect glucose changes for typical concentrations found in brain extracellular medium (Dunn-Meynell et al., 2009; Silver and Erecinska, 1994) .
To exclude that the whole-cell approach used so far could affect cell responses by altering the concentration of intracellular metabolites and other regulatory factors, we performed cellattached recordings to monitor cell excitability without interfering with cell content. Action potential firing increased by 2.3 fold (p<0.0039, n=6) when glucose concentration was lowered from 5 to 0.5mM, in the presence of synaptic blockers (Figure S1C-D), ruling out any significant effect of the recording procedure on the response of Glut2 neurons to glucose.
Leak Potassium Channels Drive the Glucose Response of Glut2 Neurons
We further investigated ionic conductances underlying glucose-induced inhibition in Glut2
neurons. The cell depolarization paired with Rinput increase under lowered glucose ( Figure 1D -E), suggested a mechanism involving the closure of a conductance for hyperpolarizing ions. Under recording conditions used in these experiments, calculated equilibrium potential for main ion species present indicated that only K + (EK=-101mV) and Cl -(ECl=-75mV) currents would reverse at more hyperpolarized values than the resting membrane potential. We therefore acquired current-voltage (IV) relationships at different glucose concentrations. Switching glucose from 5mM to 0.5mM resulted in a reversible decrease in the IV curve slope (Figure 2A ), corresponding to an increase of 323±68 MΩ in Rinput (p<6.4x10 -4 , n=12) in agreement with the change measured by periodic current pulse injection during continuous voltage recordings. In addition, IV curves showed that whole-cell currents varied monotonically with glucose concentration with the same non-linear dependency than cell properties measured previously ( Figure S2A ). Net glucose-induced current was calculated as the difference between current values measured at 5mM and 0.5mM. IV curve of net glucose current showed a reversal potential of -95.5±2.0mV, indicating a conductance selective for K + (Figure 2A ). Moreover, this IV curve had an outward rectifying trend well described by the Goldman-Hodgkin-Katz (GHK) current equation (Figure 2A) , which pointed to a leak K + channel (Burdakov et al., 2006) . The kinetics of net glucose-induced currents during voltage steps, consisting in a fast activation and an absence of decay over time (Figure 2A ), are further attributes in favor of a leak K + conductance (Burdakov et al., 2006) . The shape of net glucose current IV curve clearly excluded a voltage-gated K + channel or an inward rectifying K + channel. Calcium-dependent K + channels were unlikely to contribute to glucose effect since no changes in AHP and spike frequency adaptation were observed (Table S2) .
To confirm the nature of the conductance responsible for the glucose effect, we performed recordings using a pipette solution with elevated Cl -in order to shift the calculated equilibrium potential of this ion to a value more depolarized than resting membrane potential (ECl=0mV). In this condition, if Cl -channels were involved, their opening at 5mM glucose would lead to an excitatory effect while decreasing glucose would result in inhibition. Instead, switching from 5mM to 0.5mM glucose produced a depolarization (ΔVm=9.8±1.3mV, p<1.9x10 -5 , n=11; Figure   2B ,D) and an increase in cell excitability (ΔFI gain=0.132±0.041 Hz/pA, p<0.0047, n=9;
ΔRheobase=-51.9±17.3 pA, p<0.016, n=9; Figure 2D ) similar to the ones obtained with low pipette Cl -, supporting the sole implication of K + channels. Continuous recording of glucoseinduced current with high intrapipette Cl -in the presence of tetrodotoxin unveiled an outward current of 18.6±4.5 pA consistent with the closure of a K + conductance ( Figure 2C ). In agreement with the implication of leak K + channels, net glucose-induced current displayed an outward rectification and reversed at a similar value than with low Cl -intracellular solution (Erev=-103.8±3.6mV, p>0.066; Figure S2B ).
We also pharmacologically probed the ionic mechanism of glucose effect. Bath application of leak K + channel blocker quinine (200 µM) produced an increase in Vm (ΔVm=12.4±2.2mV, p<0.003, n=6) and Rinput (ΔRinput=506±172 MΩ, p<0.033, n=6; Figure 2E -F) and an inward shift of the IV curve ( Figure S2C ) indicative of the closure of a hyperpolarizing resting conductance.
The quinine-inhibited current, obtained by subtracting currents before and after quinine application, was outward rectifying, reversed at -97.5±2.8mV and was fitted by the GHK current equation (r2=0.98) (Figure S2C ), confirming the expression of functional leak K + channels by NTS Glut2 neurons at rest. Furthermore, quinine prevented electrophysiological changes induced by lowering glucose concentration, (ΔVm=1.5±1.2mV, p<0.27; ΔRinput=72±36 MΩ, p<0.11, n=6;
Figure 2E-F), showing that leak K + channels are required for the glucose response.
Glucose Metabolism Is Required for Glucose Sensing by Glut2 Neurons
We next tested if changes in Glut2 neuron excitability depended on glucose metabolism.
Superfusion of the metabolic inhibitor 2-deoxyglucose (2-DG, 10mM) in the presence of 5mM glucose induced an increase in Vm (ΔVm=6.8±1.1mV, p<0.003, n=5) and Rinput (ΔRinput=263±76 MΩ, p<0.026, n=5; Figure 3A -B) that mimicked the changes in membrane properties observed when lowering extracellular glucose, indicating that integrity of glucose metabolic pathways is important for the effect of glucose on these neurons. We then tested whether superfusion of glucokinase competitive inhibitor D-glucosamine in the presence of high glucose would mimic the effect of glucoprivation on Glut2 neurons. D-glucosamine (10mM) produced similar changes on resting membrane properties than glucose depletion (ΔVm=5.8±1.0mV, p<0.0014, n=7;
ΔRinput=182±53 MΩ, p<0.014, n=7; Figure 3C-D) , showing that the glucose-induced inhibition of Glut2 neurons depends on intracellular processing of glucose. Studies on glucose sensing mechanisms in other brain areas have reported direct effects of glucose on cell membrane without involvement of glucose metabolism (Gonzalez et al., 2009; O'Malley et al., 2006) . To investigate whether glucose had a similar action on Glut2 neurons in NTS, we performed wholecell recordings with glucose present in the pipette. In this condition, where intracellular glucose metabolism is rendered independent from extracellular supply, responses to changes in extracellular glucose were abolished (ΔVm=-0.5±0.4mV, p>0.22, n=7; ΔRinput=-11±19 MΩ, p>0.59, n=7; Figure 3E-F) . Nevertheless, adding D-glucosamine to these neurons still produced a glucoprivic pattern of membrane response (ΔVm=5.4±0.9mV, p<0.0014, n=6; ΔRinput=407±123 MΩ, p<0.022; n=6; Figure 3E-F) , indicating that the presence of glucose in the pipette did not result in a non-specific blunting of cell responsiveness. These experiments confirmed that glucose sensing mechanism requires cellular glucose uptake and catabolism.
Glucose Response Is Mediated by AMPK
We hypothesized, in agreement with former results, that glucose effect on Glut2 neurons is mediated by changes in cellular energy levels. Inducing a cellular ATP depletion by the superfusion on mitochondrial ATPase inhibitor Oligomycin (12 µM) resulted in an increase in Vm (ΔVm=7.2±1.7mV, p<0.006, n=7) and Rinput (ΔRinput=474±102.3 MΩ, p<0.004, n=7; Figure   4A -B) similar to the changes in membrane properties produced by low glucose levels, suggesting that a decrease of ATP supply is the main signal driving the response to glucoprivation.
Because AMP-activated protein kinase (AMPK) is a key sensor of cellular energy levels activated by ATP depletion and it is known to play an important role in the central regulation of energy homeostasis (Lage et al., 2008) , we looked at its implication in the response of Glut2 neurons to glucose. Bath application of AMPK activator AICAR (500 µM) produced similar effects than glucoprivation (ΔVm=8.5±1.4mV, p<0.001; ΔRinput=411±129 MΩ, p<0.020, n=7; Figure 4C-D) . In addition, AMPK inhibitor Compound C (150 µM) reversed the response to low glucose (ΔVm=-5.1±1.2mV, p<0.006; ΔRinput=-396±92 MΩ, p<0.005, n=7) and blocked glucose-dependent changes (ΔVm=-0.6±0.5mV, p<0.3; ΔRinput=27±57 MΩ, p<0.7, n=7; Figure   4E -F). Finally, we detected the expression of AMPK by immunohistochemistry in 67.9 % of NTS Glut2 neurons (n=109, Figure 4G ). Together, these results demonstrate that AMPK mediates glucose sensing in NTS Glut2 neurons.
We then performed immunohistochemistry to determine the nature of the Glut2-expressing cells. We observed that GAD67, a marker of GABAergic inhibitory neurons, was expressed in 80% of tdT+ cells (n=110; Figure 5A ). Glut2 neurons also frequently expressed parvalbumin (PV), a marker found in GABAergic cells subpopulations ( Figure 5B) . GABAergic projections from NTS were previously shown to drive DMNX responses to glycemic changes (Ferreira et al., 2001 ). To check whether NTS Glut2 neurons project to DMNX, we filled them with biocytin during whole-cell recording and post-processed slices to reveal axonal projections of recorded cells with confocal microscopy. Co-immunostaining for choline acetyltransferase (ChAT) was used to localize DMNX cholinergic cells. Biocytin-filled axons from some of the NTS tdTomato-positive neurons we recorded could be followed down to DMNX ( Figure 5C ), with axons showing enlargements reminiscent of axonal boutons in this area ( Figure 5C ). This suggests that NTS Glut2 neurons provide GABAergic input to DMNX.
NTS Glut2 Neurons Activate the Vagus and Glucagon Secretion In Vivo
We sought to determine the role of Glut2 neurons in vivo. Because Glut2 neurons respond to low glucose levels and project to vagal motor neurons, we reasoned they may affect vagal output and drive the counterregulatory response to hypoglycemia. To test this hypothesis we used an optogenetics approach. We crossed Glut2-Cre mice with a Rosa26ChR2-YFP reporter line (Madisen et al., 2012) to express channelrhodopsin (ChR2) in Glut2 neurons. We recorded these cells by whole-cell patch-clamp in acute NTS slices to check the efficiency of ChR2 expression ( Figure 6A ). Blue light illumination (473 nm) induced a reversible photocurrent and action potential firing (Figure 6B and S3A) . When using pulsed (10ms) illumination, the frequency of both photocurrents and action potentials increased with that of light pulses ( Figure 6C and S3B-C). In vivo optogenetic stimulations were performed in anesthetized mice while vagal activity was recorded. An optical fiber was positioned with a stereotaxic micromanipulator at the dorsal face of the NTS to deliver pulses of blue light ( Figure 6D) . Light stimulation induced a rapid increase of vagal firing rate in ChR2-expressing animals but not in Cre-/ChR2+ littermates (p<0.0001, 2-way anova, n=6; Figure 6E ). Blood glucagon levels, measured shortly after the end of the stimulation, where significantly higher in ChR2-expressing animals as compared to
Cre-/ChR2+ controls (glucagon=105.0±31.7, n=7 vs. 326.5±66.1 pg/ml, n=6, p<0.009; Figure 6F ). No differences in basal glucagonemia existed between the 2 groups (glucagon=135.0±51.5, n=11 vs. 143.4±21.6 pg/ml, n=10, p<0.9; Figure 6F ). These data evidence a role for NTS Glut2 neurons in the control of the parasympathetic regulation of glucagon secretion.
DISCUSSION
Our results establish that expression of the glucose transporter isoform Glut2 identifies a homogenous glucose-sensing neuronal subpopulation in the nucleus of the tractus solitarius.
These Glut2 neurons are glucose-inhibited cells whose response depends on intracellular glucose metabolism-driven changes in permeability of background potassium channels; they are GABAergic inhibitory neurons. Optogenetic activation of these NTS Glut2 neurons activates parasympathetic nerve firing and glucagon secretion, suggesting that they play an important role in the counterregulatory response to hypoglycemia.
Glucose-sensing neurons have been identified in several brain areas involved in the control of energy homeostasis and related behaviors (Thorens, 2012) . In the dorsal vagal complex, about 20% of neurons respond to glucose with either a GE or a GI pattern (Balfour et al., 2006; Yettefti et al., 1997) . GI neurons in this structure use a variety of molecular mechanisms to couple hypoglycemia to changes in membrane excitability (Balfour and Trapp, 2007) , indicating that they form a diverse population of glucose-responsive cells. Their precise topographical and functional characterization is however difficult to assess because of the absence of specific markers allowing their identification. In this study, we found Glut2 to consistently single out a specific population of GI neurons in NTS. This glucose transporter isoform was first described for its role in glucose sensing in pancreatic beta-cells leading to insulin secretion. Previous data suggested that it might hold a similar role in central glucose detection (Marty et al., 2005; Mounien et al., 2010) and in the control by glucose of the parasympathetic and sympathetic nervous activities (Tarussio et al., 2014) . Here we provide evidence for the functional association of Glut2 with glucose-sensing in neurons. Whole-cell and cell-attached recordings showed that lowering glucose increased excitability of Glut2-expressing neurons, an effect relying on glucose metabolism, and on the subsequent closure of leak K + channels. A mediator of this response is an increase in intracellular AMP/ATP ratio that activates AMP-kinase, as shown for the response of other GI neurons such as those of the VMH (Murphy et al., 2009 ).
Membrane depolarization of GI neurons has been attributed to diverse mechanisms, including the reduction of Na + /K + ATPase activity (Balfour and Trapp, 2007) , the AMP-kinasedependent inhibition of the CFTR chloride conductance (Murphy et al., 2009) , or the closure of leak K + channels (Balfour and Trapp, 2007; Burdakov et al., 2006) . We show that NTS Glut2 neurons' response to low glucose depends on a leak K + channel. However, in contrast to NTS Glut2 neurons, leak K + channel-driven glucoprivic signaling in LH orexin neurons does not require glucose uptake or metabolism, but a putative cell surface receptor (Gonzalez et al., 2009 ).
Thus, hypoglycemia can use different signaling pathways to control the same membrane
conductances.
An important observation is that depolarization of Glut2 NTS neurons increased progressively as external glucose concentrations decreased below euglycemic-like levels, however within the physiological extracellular concentration range found in the brain. Thus, glucose-sensitive Glut2-expressing neurons are in a position to fine-tune NTS glucoregulatory responses over physiological glucose concentrations.
Numerous studies indicated that brainstem and NTS glucose-responsive neurons are involved in whole body glucoregulation, such as neuroglucopenia-induced counterregulation and stimulation of feeding (Briski and Marshall, 2000; Dunn-Meynell et al., 2009) . It was also shown that NTS neurons were connected to pancreas-projecting DMNX neurons by retrograde labeling using pseudorabies viruses (Buijs et al., 2001 ). In addition, NTS stimulation evoked GABAergic synaptic activity in DMNX (Ferreira et al., 2001 ). Here we showed that optogenetic activation of GABAergic Glut2-neurons of the NTS led to increased activity of vagal nerve and glucagon secretion. Although it is not known whether optogenetic stimulation resumes in vivo activation patterns by hypoglycemia, these results strongly suggest that NTS Glut2 neurons participate to physiological glucoregulatory responses.
Activation of parasympathetic nerves by NTS GABA neurons is consistent, on the one hand, with our observation that NTS Glut2 neurons send projections into the DMNX and, on the other hand, with the demonstration that a sizeable fraction of the NTS GABAergic input to the DMNX activates vagal nerves through inhibition of local tonic inhibitory neurons (Babic et al., 2011) . The fact that hypoglycemia-induced parasympathetic activity stimulates glucagon secretion is well established (Berthoud et al., 1990; Patel, 1984) . Parasympathetic activity triggers the initial counterregulatory response to hypoglycemia when blood glucose concentration falls below euglycemia whereas activation of sympathetic activity is triggered at lower glycemic levels (Taborsky and Mundinger, 2012) . In previous studies we showed that hypoglycemia or 2-DG-induced neuroglucopenia induced differential glucagon secretion in control and Glut2-null mice. Importantly, this differential response was observed at intermediate levels of hypoglycemia (2.5 mM) or following injections carefully selected doses of 2-DG. At lower glycemic levels (1 mM) or following injection of larger doses of 2-DG glucagon secretion was equally stimulated in control and knockout mice (Burcelin and Thorens, 2001; Marty et al., 2005) . We thus hypothesized that Glut2-dependent nervous glucose sensing was involved in the detection of small, physiological changes in glycemic levels, while other mechanisms, such as a direct stimulation of pancreatic α cell secretion, might take place during deeper hypoglycemia (Zhang et al., 2013) . Our present data showing that NTS Glut2 neurons are GI neurons inducing glucagon secretion through activation of parasympathetic activity is in agreement with this previous hypothesis.
Collectively, our study provides the functional characterization of a new class of glucosesensing neurons based on the expression of the Glut2 glucose transporter. They demonstrate that the NTS is indeed an important site for glucose sensing, in particular during development of hypoglycemia, which can be mobilized to induce glucagon secretion. This is an important step in elucidating the mechanisms controlling stimulated glucagon secretion in physiological conditions but also when this secretion becomes unresponsive to developing hypoglycemia, as associated with hypoglycemia associated autonomic failure (Cryer, 2006) , a serious condition that limits insulin treatment of both type 1 and type 2 diabetes.
EXPERIMENTAL PROCEDURES
Slice preparation
Sagittal slices of brainstem, 200µm thick, containing NTS were cut in ice-cold extracellular solution with 10mM glucose using a vibratome and were maintained in an incubation chamber at room temperature until used.
Electrophysiology
Slices were placed in a submerged-type recording chamber and continuously superfused with extracellular solution at room temperature. TdTomato-expressing neurons were localized by confocal epifluorescence microscopy. Whole-cell recordings from visually identified neurons where obtained with borosilicate glass pipettes. Continuous recordings of Vm were used to monitor the effect of glucose and drugs. Hyperpolarizing current pulses were periodically injected to monitor Rinput.
Step protocols were used for additional measurements of cell properties. Cell attached recordings were performed on slice superfused with an extracellular solution promoting spontaneous firing.
Data analysis
Electrophysiological data were analyzed with pClamp10 (Molecular Devices). Voltages were corrected for calculated liquid junction potentials. Pooled data were presented as mean ± SEM.
Statistical analysis and curve fitting were done with Origin8.5 (OriginLab). Statistical testing was performed with paired and unpaired 2-tailed Student's t tests unless stated otherwise.
Differences were considered significant for p < 0.05 (* p<0.05; ** p<0.01; *** p<0.001, n.s., non significant).
Single cell RT-PCR
The single-cell content was aspirated with a patch pipette and expelled into an RNase free PCR tube for reverse transcription. We then performed two successive PCR rounds. The first round of used the cDNAs present in the reverse transcription reaction as template. The second round used 10µl of the first PCR product as template. The products of the second PCR round were analyzed on agarose gel using ethidium bromide.
Immunostaining were done on brainstem cryosections obtained from mice perfused with 4%
paraformaldehyde. Sections were incubated with primary monoclonal antibodies against GAD67 (MAB5406, Chemicon), PV (PV235, Swant), pAMPK (ab2535, Cell Signaling) and with an anti-mouse FITC-coupled secondary antibody. To reveal biocytin-filled neurons, acute slices were fixed with PFA 4% after recording and incubated with Cascade Blue-Neutravidin (A2663, Invitrogen). In addition, immunosatining was performed on these slices with a monoclonal antibody against choline acetyltransferase (ab35948, Abcam).
Image acquisition and processing
Confocal images of immunostained cryosections and acute slices were obtained and processed with Image J (Rasband, W.S., NIH, Bethesda, Maryland, USA) to obtain maximum intensity projection representations. High resolution images were deconvolved with Huygens (Scientific Volume Imaging, Hilversum, The Netherlands). In addition, three-dimensional surface renderings were produced with Imaris (Bitplane, Zurich, Switzerland).
Optogenetics experiments
ChR2-expresing neurons were activated with a blue laser (473 nm, 100 mW, RappOptoelectronics) coupled to an optical fiber (200 µm core, Thorlabs). For slice experiments, the fiber was attached to a micromanipulator and brought close to the recorded cell. Blue lightinduced photo-currents and action potentials were recorded. For in vivo experiments, the fiber was positioned above the NTS of anesthetized mice with a stereotaxic apparatus. Repetitive trains of blue light pulses were applied for 40 min. The firing rate of the vagus nerve was monitored during the stimulation. Blood glucagon levels were dosed by radioimmunoassay shortly after the end of the stimulation. 
